For the Inventor, By the Inventor

Enter assignee name

Seattle, WA, United States of America

Adaptive Biotechnologies Corporation

USPTO Granted Patents = 56

CIPO Patents = 3

EPO Patents = 29

Trademarks = 16

Forward Citations = 686

Loading Chart...

Loading Chart...

39 inventors (with patents filed for the assignee):

Malek Faham (27 out of 54 patents)

Harlan Saul Robins (25 out of 31 patents)

Thomas Willis (16 out of 30 patents)

4. Ryan O Emerson (15 out of 18 patents)

5. Anna M Sherwood (12 out of 12 patents)

6. Mark Klinger (11 out of 13 patents)

7. Christopher Scott Carlson (7 out of 10 patents)

8. Robert J Livingston (7 out of 9 patents)

9. Martin Moorhead (7 out of 9 patents)

10. Jianbiao Zheng (6 out of 15 patents)

11. Mark J Rieder (4 out of 10 patents)

12. Thomas Asbury (4 out of 4 patents)

13. Li Weng (3 out of 23 patents)

14. Julie Rubinstein (3 out of 3 patents)

15. Jianda Yuan (3 out of 3 patents)

Core Competencies:

Immune Repertoire Sequencing

T Cell Receptor Sequences

Clonotype Profiles

Antigen-Specific T Cells

Nucleic Acid Sequencing

Adaptive Immune Response

Multiplexed PCR Reactions

Immunocompetence Assessment

Lymphoid Malignancies

Monoclonal Antibodies

Sequence Analysis

Tissue-Infiltrating Lymphocytes

56 patents: Sort by Forward Citations

1. 12428682 - Methods for diagnosing infectious disease and determining HLA status using immune repertoire sequencing (2025-09-30),

2. 12351872 - Determining antigen-specific T-cells (2025-07-08),

3. 12266425 - T cell receptor sequences diagnostic for COVID-19 and related compositions (2025-04-01),

4. 12263179 - Lyme disease-associated T cell receptor-related methods (2025-04-01),

5. 12209282 - Monitoring health and disease status using clonotype profiles (2025-01-28),

6. 12195795 - Synthetic strands for nucleic acid sequencing and related methods and systems (2025-01-14),

7. 12104211 - Immunocompetence assessment by adaptive immune receptor diversity and clonality characterization (2024-10-01),

8. 11773442 - Method for studying V(D)J combinatory diversity (2023-10-03),

9. 11708605 - Synthetic strands for nucleic acid sequencing and related methods and systems (2023-07-25),

10. 11390921 - Determining WT-1 specific T cells and WT-1 specific T cell receptors (TCRs) (2022-07-19),

11. 11261490 - Determining antigen-specific T-cells (2022-03-01),

12. 11254980 - Methods of profiling targeted polynucleotides while mitigating sequencing depth requirements (2022-02-22),

13. 11248253 - Methods using randomer-containing synthetic molecules (2022-02-15),

14. 11180813 - Immunocompetence assessment by adaptive immune receptor diversity and clonality characterization (2021-11-23),

15. 11066705 - Characterization of adaptive immune response to vaccination or infection using immune repertoire sequencing (2021-07-20),

Adaptive Biotechnologies is a biotechnology company that specializes in harnessing the power of the adaptive immune system to transform the diagnosis and treatment of diseases. With their proprietary immune profiling platform, they aim to decode the adaptive immune system to accurately diagnose and monitor diseases such as cancer, autoimmune disorders, and infectious diseases. Through their collaborations with pharmaceutical and clinical partners, Adaptive Biotechnologies is working towards developing personalized therapies and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 23 2025

56 Patents

#39 in Seattle, WA

#118 in Washington

#6,130 in US

#12,351 in the World

Seattle, WA, United States of America

Adaptive Biotechnologies Corporation

Forward Citations = 686

39 inventors:

Malek Faham (27 out of 54 patents)

Harlan Saul Robins (25 out of 31 patents)

Thomas Willis (16 out of 30 patents)

4. Ryan O Emerson (15 out of 18 patents)

5. Anna M Sherwood (12 out of 12 patents)

Please report any incorrect information to support@idiyas.com

Loading…